PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Migraine and Contraception: Aura Status and Vascular Risk Drive Method Choice

migrainemigraine with auracombined hormonal contraceptivesprogestin-only contraceptivesethinyl estradioldesogestreldrospirenoneestetrolischemic strokenarrative reviewwomen's healthcontraception Women's Health / Reproductive

Background Information

Safe contraceptive choices for women with migraine are critical due to stroke risk.

Contraceptive choices for women with migraine require careful consideration due to stroke risk and hormonal effects. Women with migraine with aura face increased stroke risk, making combined hormonal contraceptives inappropriate, while progestin-only options remain favorable. Careful evaluation of vascular risk in women with migraine can guide contraceptive choice, particularly favoring progestin-only contraceptives. Progestin-only contraceptives are safest for women with migraine with aura due to lower stroke risk.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Kozák M, Bencs V, Héja M, Mechtler L

Citation: Kozák M, Bencs V, Héja M, et al. Contraceptive decision-making in women with migraine: integrating guidelines, vascular risk, and clinical practice. Reproductive health. 2026;23(1). doi:10.1186/s12978-026-02440-8

Article Links: PubMed · Journal / DOI

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.